Aldosterone Excretion Rate and Blood Pressure in Essential Hypertension Are Related to Polymorphic Differences in the Aldosterone Synthase Gene CYP11B2
Open Access
- 1 February 1999
- journal article
- research article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 33 (2) , 703-707
- https://doi.org/10.1161/01.hyp.33.2.703
Abstract
—Significant correlation of body sodium and potassium with blood pressure (BP) may suggest a role for aldosterone in essential hypertension. In patients with this disease, the ratio of plasma renin to plasma aldosterone may be lower than in control subjects and plasma aldosterone levels may be more sensitive to angiotensin II (Ang II) infusion. Because essential hypertension is partly genetic, it is possible that altered control of aldosterone synthase gene expression or translation may be responsible. We compared the frequency of 2 linked polymorphisms, one in the steroidogenic factor-1 (SF-1) binding site and the other an intronic conversion (IC), in groups of hypertensive and normotensive subjects. In a larger population, the relationship of aldosterone excretion rate to these polymorphisms was also evaluated. In 138 hypertensive subjects, there was a highly significant excess of TT homozygosity (SF-1) over CC homozygosity compared with a group of individually matched normotensive control subjects. The T allele was significantly more frequent than the C allele in the hypertensive group compared with the control group. Similarly, there was a highly significant relative excess of the conversion allele over the “wild-type” allele and of conversion homozygosity over wild-type homozygosity in the hypertensive group compared with the control group. In 486 subjects sampled from the North Glasgow Monitoring of Trends and Determinants in Cardiovascular Disease (MONICA) population, SF-1 and IC genotypes were compared with tetrahydroaldosterone excretion rate. Subjects with the SF-1 genotypes TT or TC had significantly higher excretion rates than those with the CC genotype. The T allele was associated with higher excretion rates than the C allele. However, no significant differences were found in excretion rate between subjects of different IC genotype. Urinary aldosterone excretion rate may be a useful intermediate phenotype linking these genotypes to raised BP. However, no causal relationship has yet been established, and it is possible that the polymorphisms may be in linkage with other causative mutations.Keywords
This publication has 18 references indexed in Scilit:
- Primary aldosteronism. Part II Differential diagnosis of primary hyperaldosteronism and pseudoaldosteronismClinical Endocrinology, 1996
- Primary aldosteronism. Part I Diagnosis of primary hyperaldosteronismClinical Endocrinology, 1996
- Polymorphism of the angiotensin I converting enzyme gene is apparently not related to high blood pressure: Dutch Hypertension and Offspring StudyJournal Of Hypertension, 1993
- The angiotensin I converting enzyme gene and predisposition to high blood pressure.Hypertension, 1993
- Molecular basis of human hypertension: Role of angiotensinogenCell, 1992
- Absence of linkage between the angiotensin converting enzyme locus and human essential hypertensionNature Genetics, 1992
- Similar frequencies of renin gene restriction fragment length polymorphisms in hypertensive and normotensive subjects.Hypertension, 1990
- A lack of genetic linkage of renin gene restriction fragment length polymorphisms with human hypertension.Hypertension, 1989
- Response of aldosterone and 18-hydroxycorticosterone to angiotensin II in normal subjects and patients with essential hypertension, Conn's syndrome, and nontumorous hyperaldosteronism.Hypertension, 1981
- Increased Adrenal Sensitivity to Angiotensin II in Low-Renin Essential HypertensionJournal of Clinical Investigation, 1978